Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 April 2008

Cardiovascular risk reduction and factors influencing loss to follow-up in the coronary health improvement project

Ray M. Merrill, Steven G. Aldana

Med Sci Monit 2008; 14(4): PH17-25 :: ID: 850307

Abstract

Background: This study determined whether the Coronary Health Improvement Project (CHIP) can improve cardiovascular disease risk factors through one year of follow-up and identified factors influencing loss to follow-up.
Material/Methods: The CHIP program, an intensive four week community-based health education intervention designed to improve coronary risk factors, was evaluated using a quasi-experimental design. Analyses were based on 1,712 community volunteers, ages 30 to 87 from the Rockford, Illinois Metropolitan area. Of the participants, 97.7% completed the lifestyle evaluation at both baseline and after four weeks, and 51% provided data through one year.
Results: Participants showed significant improvements in all cardiovascular risk factors considered (body mass index, resting heart rate, systolic blood pressure, diastolic blood pressure, cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides, and glucose) after both four weeks and one year. Loss to follow-up was highest among those who were ages 30–39, had a history of diabetes, had a history of being overweight, smoked, lived with a heavy smoker, were physically less active, or were experiencing stress. Those with higher BMI, SBP, DBP, or glucose at baseline were also more likely to be lost to follow-up through one year. Those who failed to improve their BMI, resting heart rate, serum cholesterol, HDL, LDL, triglycerides, or glucose after four weeks were 16%, 9%, 22%, 21%, 16%, 22%, and 15% more likely to be lost to follow-up, respectively.
Conclusions: The CHIP program improves cardiovascular disease risk factors through one year of follow-up. Poorer health status at baseline is associated with increased loss to follow-up. Failure to improve one or more cardiovascular risk factors after four weeks of intervention is predictive of loss to follow-up through one year.

Keywords: Aged, 80 and over, Cardiovascular Diseases - prevention & control, Follow-Up Studies, Health, Risk Factors, Risk Reduction Behavior

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750